Off-Label Use of Biological Therapies in Systemic Autoimmune Diseases.

被引：0
|
作者：
Araujo, Ana Carolina [1 ]
Noronha, Carla [1 ]
Grilo, Ana [1 ]
Moraes-Fontes, Maria Francisca [1 ]
Riso, Nuno [1 ]
Riscado, Manuel Vaz [1 ]
机构：
[1] Hosp Curry Cabral, Lisbon, Portugal
来源：
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1971
引用
收藏
页码：S766 / S766
页数：1
相关论文
共 50 条
  • [1] A Systematic Review of the Off-Label Use of Biological Therapies in Systemic Autoimmune Diseases
    Ramos-Casals, Manuel
    Brito-Zeron, Pilar
    Munoz, Sandra
    Soto, Maria-Jose
    [J]. MEDICINE, 2008, 87 (06) : 345 - 364
  • [2] Off-label use of biological therapies in systemic diseases
    Hachulla, E.
    [J]. REVUE DE MEDECINE INTERNE, 2010, 31 : S307 - S314
  • [3] Use of biological therapies in systemic autoimmune diseases
    Pallares, L.
    Esteban, E.
    Rascon, J.
    [J]. MEDICINA BALEAR, 2008, 23 (03): : 32 - 36
  • [4] Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases
    Ramos-Casals, M.
    Garcia-Hernandez, F. J.
    de Ramon, E.
    Callejas, J. L.
    Martinez-Berriotxoa, A.
    Pallares, L.
    Caminal-Montero, L.
    Selva-O'Callaghan, A.
    Oristrell, J.
    Hidalgo, C.
    Perez-Alvarez, R.
    Mico, M. L.
    Medrano, F.
    Gomez-de-la-Torre, R.
    Diaz-Lagares, C.
    Camps, M.
    Ortego, N.
    Sanchez-Roman, J.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (04) : 468 - 476
  • [5] The off-label use of anakinra in pediatric systemic autoinflammatory diseases
    Maniscalco, Valerio
    Abu-Rumeileh, Sarah
    Mastrolia, Maria Vincenza
    Marrani, Edoardo
    Maccora, Ilaria
    Pagnini, Ilaria
    Simonini, Gabriele
    [J]. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2020, 12
  • [6] OFF-LABEL USE OF BIOLOGICAL THERAPIES IN RELAPSING AND/OR REFRACTORY POLYARTERITIS NODOSA
    Canzian, Alice
    Karadag, Omer
    Contis, Anne
    Maurier, Francois
    Sartorelli, Silvia
    Denis, Laure
    Sanges, Sebastien
    De Moreuil, Claire
    Durel, Cecile-Audrey
    Durupt, Stephane
    Jachiet, Marie
    Rouzaud, Diane
    Salvarani, Carlo
    Schiavon, Franco
    Dagna, Lorenzo
    Bonnet, Fabrice
    Jayne, David
    Guillevin, Loic
    Terrier, Benjamin
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1186 - 1187
  • [7] Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label
    Cándido Díaz-Lagares
    Roberto Pérez-Alvarez
    Francisco J García-Hernández
    María M Ayala-Gutiérrez
    José Luis Callejas
    Agustín Martínez-Berriotxoa
    Javier Rascón
    Luis Caminal-Montero
    Albert Selva-O'Callaghan
    Joaquim Oristrell
    Carmen Hidalgo
    Ricardo Gómez-de-la-Torre
    Luis Sáez
    Jesús Canora-Lebrato
    María-Teresa Camps
    Norberto Ortego-Centeno
    María-Jesús Castillo-Palma
    Manuel Ramos-Casals
    [J]. Arthritis Research & Therapy, 13
  • [8] Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a review
    Atzeni, F
    Sarzi-Puttini, P
    Doria, A
    Iaccarino, L
    Capsoni, F
    [J]. AUTOIMMUNITY REVIEWS, 2005, 4 (03) : 144 - 152
  • [9] Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label
    Diaz-Lagares, Candido
    Perez-Alvarez, Roberto
    Garcia-Hernandez, Francisco J.
    Ayala-Gutierrez, Maria M.
    Luis Callejas, Jose
    Martinez-Berriotxoa, Agustin
    Rascon, Javier
    Caminal-Montero, Luis
    Selva-O'Callaghan, Albert
    Oristrell, Joaquim
    Hidalgo, Carmen
    Gomez-de-la-Torre, Ricardo
    Saez, Luis
    Canora-Lebrato, Jesus
    Camps, Maria-Teresa
    Ortego-Centeno, Norberto
    Castillo-Palma, Maria-Jesus
    Ramos-Casals, Manuel
    [J]. ARTHRITIS RESEARCH & THERAPY, 2011, 13 (04)
  • [10] Off-label use of rituximab in systemic rheumatic diseases: case series
    Araujo, Filipe
    Silva, Ines
    Sepriano, Alexandre
    Nero, Patricia
    Branco, Jaime C.
    [J]. ACTA REUMATOLOGICA PORTUGUESA, 2013, 38 (04): : 290 - 294
12345